Global Semi-solid Dosage Cdmo Market Size & Outlook
Global semi-solid dosage cdmo market, 2018-2030 (US$M)
Related Markets
Global semi-solid dosage cdmo market highlights
- The global semi-solid dosage cdmo market generated a revenue of USD 34,514.2 million in 2024 and is expected to reach USD 67,395.9 million by 2030.
- The market is expected to grow at a CAGR (2025 - 2030) of 11.9% by 2030.
- In terms of segment, topical accounted for a revenue of USD 34,036.8 million in 2024.
- Transdermal is the most lucrative route of administration segment registering the fastest growth during the forecast period.
- In terms of region, North America was the largest revenue generating market in 2024.
- Country-wise, India is expected to register the highest CAGR from 2025 to 2030.
Global data book summary
| Market revenue in 2024 | USD 34,514.2 million |
| Market revenue in 2030 | USD 67,395.9 million |
| Growth rate | 11.9% (CAGR from 2025 to 2030) |
| Largest segment | Topical |
| Fastest growing segment | Transdermal |
| Historical data covered | 2018 - 2023 |
| Base year for estimation | 2024 |
| Forecast period covered | 2025 - 2030 |
| Quantitative units | Revenue in USD million |
| Market segmentation | Topical, Transdermal |
Other key industry trends
- In terms of revenue, the North America accounted for 41.4% of the global semi-solid dosage cdmo market in 2024.
- By country, the U.S. is projected to lead the global market in terms of revenue in 2030.
- By country, India is the fastest growing regional market and is projected to reach USD 2,810.1 million by 2030.
No credit card required*
Horizon in a snapshot
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
Semi-Solid Dosage CDMO Market Scope
Semi-Solid Dosage CDMO Market Companies
| Name | Profile | # Employees | HQ | Website |
|---|---|---|---|---|
| LGM Pharma | View profile | 101-250 | Nashville, Tennessee, United States, North America | https://lgmpharma.com/ |
| DPT Laboratories | View profile | 1001-5000 | San Antonio, Texas, United States, North America | https://www.dptlabs.com |
| Ascendia Pharmaceuticals | View profile | 101-250 | North Brunswick, New Jersey, United States, North America | https://ascendiapharma.com/ |
| Bora Pharmaceuticals | View profile | 501-1000 | Taipei, T'ai-pei, Taiwan, Asia | http://www.bora-corp.com/ |
| Contract Pharmaceuticals Limited | View profile | 251-500 | Mississauga, Ontario, Canada, North America | http://www.cplltd.com |
| Pierre Fabre | View profile | 10001+ | Castres-gironde, Aquitaine, France, Europe | http://www.pierre-fabre.com |
| Cambrex | View profile | 1001-5000 | East Rutherford, New Jersey, United States, North America | http://www.cambrex.com |
| Pace Analytical Services | View profile | 11-50 | Woburn, Massachusetts, United States, North America | https://www.pacelifesciences.com |
| Piramal Pharma Solutions | View profile | 1001-5000 | Riverview, Michigan, United States, North America | http://www.piramalpharmasolutions.com/ |
| The Lubrizol Corp | View profile | 5001-10000 | Wickliffe, Ohio, United States, North America | http://www.lubrizol.com/ |
Global semi-solid dosage cdmo market outlook
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to semi-solid dosage cdmo market will help companies and investors design strategic landscapes.
Topical was the largest segment with a revenue share of 98.62% in 2024. Horizon Databook has segmented the Global semi-solid dosage cdmo market based on topical, transdermal covering the revenue growth of each sub-segment from 2018 to 2030.
- Global Semi-Solid Dosage CDMO Route of Administration Outlook (Revenue, USD Million, 2018-2030)
- Topical
- Transdermal
- Others
- Global Semi-Solid Dosage CDMO Product Outlook (Revenue, USD Million, 2018-2030)
- Ointments
- Creams and Lotions
- Pastes
- Gels
- Others
- Global Semi-Solid Dosage CDMO Service Outlook (Revenue, USD Million, 2018-2030)
- Contract Manufacturing
- Contract Development
- Global Semi-Solid Dosage CDMO End Use Outlook (Revenue, USD Million, 2018-2030)
- Pharmaceutical Companies
- Biopharmaceutical Companies
- Others
Reasons to subscribe to Global semi-solid dosage cdmo market databook:
-
Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
-
Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
-
Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
-
Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
-
Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.
Target buyers of Global semi-solid dosage cdmo market databook
-
Our clientele includes a mix of semi-solid dosage cdmo market companies, investment firms, advisory firms & academic institutions.
-
30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
-
Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
-
The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.
Horizon Databook provides a detailed overview of global-level data and insights on the Global semi-solid dosage cdmo market , including forecasts for subscribers. This global databook contains high-level insights into Global semi-solid dosage cdmo market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Partial client list
Global semi-solid dosage cdmo market size, by regions, 2018-2030 (US$M)
Top 10 countries: Semi-solid dosage cdmo market size, 2024 (US$M)
Global semi-solid dosage cdmo market share, by route of administration, 2024 & 2030 (%, US$M)
Semi-solid dosage cdmo market: Opportunity assessment by country
Global semi-solid dosage cdmo market, by region, 2024 (US$M)
Related industry reports
Related statistics
Sign up - it's easy, and free!
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
